Status:
RECRUITING
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Lead Sponsor:
Technical University of Munich
Collaborating Sponsors:
Helmholtz Zentrum München
Charite University, Berlin, Germany
Conditions:
Metabolomics
Critical Care
Eligibility:
All Genders
18+ years
Brief Summary
In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at ...
Eligibility Criteria
Inclusion
- invasive mechanically ventilated critically ill patient with expected intensive care unit stay \> 3 days
- postoperative patient
- ≥ 18 years old
- American Society of Anesthesiology (ASA) classification ≥ III
Exclusion
- moribund patient
- non-curative care (comfort care)
Key Trial Info
Start Date :
September 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03810768
Start Date
September 2 2022
End Date
December 31 2026
Last Update
September 18 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna, Austria, 1090
2
Klinikum rechts der Isar, School of Medicine, Technical University of Munich
Munich, Bavaria, Germany, 81675
3
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 10117